Arkolith/Insider Trading/TCON/Form 4

Opaleye Management Inc.

10% OwnerTracon Pharmaceuticals, Inc. (TCON) · full profile →Form 4 · filed Dec 29, 2021
Net Buying
Open-Market Buys
$308K
Open-Market Sells
$0
Net Open-Market Flow
$308K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 28, 2021Buy(P)20K$2.63$53K285K
Dec 28, 2021Buy(P)125$2.63$3302.7M
Dec 27, 2021Buy(P)75K$2.92$219K2.6M
Dec 27, 2021Buy(P)12K$2.92$36K265K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-21-032688) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML